Pharmacological targeting of MCL-1 promotes mitophagy and improves disease pathologies in an Alzheimer’s disease mouse model
Previous work suggests that mitophagy in neurons is could be therapeutic in Alzheimer’s disease (AD). Here, the authors screen a library of drugs and identify UMI-77, a mitophagy inducer with beneficial effects in an AD mouse model, by binding MCL-1, which they identify as a mitophagy receptor.
Guardado en:
Autores principales: | Xufeng Cen, Yanying Chen, Xiaoyan Xu, Ronghai Wu, Fusheng He, Qingwei Zhao, Qiming Sun, Cong Yi, Jie Wu, Ayaz Najafov, Hongguang Xia |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0778027b69704574ad5fc700df51b76a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mitophagy Disequilibrium, a Prominent Pathological Mechanism in Metabolic Heart Diseases
por: Li Y, et al.
Publicado: (2021) -
Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
por: Dona Pamoda W. Jayatunga, et al.
Publicado: (2021) -
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
por: Moxin Wu, et al.
Publicado: (2021) -
ARIH1 signaling promotes anti-tumor immunity by targeting PD-L1 for proteasomal degradation
por: Youqian Wu, et al.
Publicado: (2021) -
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: Francesca La Rosa, et al.
Publicado: (2021)